中國恆大(03333.HK)委任恆大汽車董事長肖恩爲執董 中國信達高層亦入局
中國恆大(03333.HK)公佈,執行總裁肖恩獲委任爲執行董事,樑森獲委任爲非執行董事。另外,賴立新及黃賢貴辭任執行董事。
50歲的肖恩爲恆大汽車(00708.HK)執行董事及董事長,及恆大集團有限公司執行總裁。肖恩於2013年11月加入公司,曾擔任公司常務副總裁、恆大旅遊集團有限公司董事長及恆大新能源汽車集團董事長,擁有逾28年商業經驗。
獲委任非執董的樑森,擁有逾30年之銀行及資產管理經驗,於2018年加入中國信達資產管理股份有限公司,自2019年5月起擔任信達香港董事長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.